On Jan. 18, 2023, the press conference on the adjustment of the national reimbursement drug list announced that Azvudine tablets was officially included in the national reimbursement drug list. Azvudine tablets is priced at 11.58 yuan/tablet/3 mg with medical insurance.
Genuine Biotech will consistently adhere to the guiding principle of prioritizing the people and their lives, and continue to provide more effective and accessible medicines for the clinical treatment of patients, so as to safeguard people's health.